THERAVANCE BIOPHARMA INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by THERAVANCE BIOPHARMA INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2018-02-08VANGUARD GROUP INCTheravance Biopharma, Inc.3,398,3326.3%EDGAR
SC 13G/A2018-01-30BlackRock Inc.Theravance Biopharma, Inc.3,743,9556.9%EDGAR
SC 13G/A2017-02-14FMR LLCTheravance Biopharma, Inc.5,770,86011.1%EDGAR
SC 13G/A2017-02-14BAUPOST GROUP LLC/MATheravance Biopharma, Inc.10,144,81919.2%EDGAR
SC 13G/A2017-02-14CF Woodford Equity Income FundTheravance Biopharma, Inc.8,365,83916.1%EDGAR
SC 13G/A2017-02-14Woodford Investment Management LtdTheravance Biopharma, Inc.10,507,60820.2%EDGAR
SC 13G2017-02-10VANGUARD GROUP INCTheravance Biopharma, Inc.2,955,0735.7%EDGAR
SC 13D/A2017-02-03GLAXOSMITHKLINE PLCTheravance Biopharma, Inc.9,644,80718.4%EDGAR
SC 13G/A2017-01-27BlackRock Inc.Theravance Biopharma, Inc.3,454,9106.7%EDGAR
SC 13G2016-11-10FMR LLCTheravance Biopharma, Inc.6,142,87311.8%EDGAR
SC 13G/A2016-08-04Woodford Investment Management LLPTheravance Biopharma, Inc.9,087,13719.1%EDGAR
SC 13D/A2016-05-13GLAXOSMITHKLINE PLCTheravance Biopharma, Inc.9,644,80720.3%EDGAR
SC 13D2016-03-24GLAXOSMITHKLINE PLCTheravance Biopharma, Inc.9,644,80724.3%EDGAR
SC 13G/A2016-02-19CF Woodford Equity Income FundTheravance Biopharma, Inc.4,744,07612.5%EDGAR
SC 13G/A2016-02-19Woodford Investment Management LLPTheravance Biopharma, Inc.5,061,63713.4%EDGAR
SC 13G/A2016-02-12BAUPOST GROUP LLC/MATheravance Biopharma, Inc.6,420,02817.0%EDGAR
SC 13G/A2016-02-09GLAXOSMITHKLINE PLCTheravance Biopharma, Inc.8,343,79222.1%EDGAR
SC 13G/A2016-01-27BlackRock Inc.Theravance Biopharma, Inc.2,411,3756.4%EDGAR
SC 13G2015-11-10Woodford Investment Management LLPTheravance Biopharma, Inc.4,220,33411.2%EDGAR
SC 13G2015-11-10CF Woodford Equity Income FundTheravance Biopharma, Inc.3,968,79010.5%EDGAR
External links